humanitarian
Human medicines European public assessment report (EPAR): Braftovi, encorafenib, Date of authorisation: 19/09/2018, Revision: 19, Status: Authorised
Human medicines European public assessment report (EPAR): Phesgo, pertuzumab,trastuzumab, Date of authorisation: 21/12/2020, Revision: 8, Status: Authorised
Reported by EMA What Is New
Read the complete report at EMA What Is New ↗
Verification notice
IntelMap indexes open-source reporting. This page identifies what a source reported; it does not independently confirm the claim.
12 reports · 2 sources
EMA What Is NewHuman medicines European public assessment report (EPAR): Braftovi, encorafenib, Date of authorisation: 19/09/2018, Revision: 19, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Braftovi, encorafenib, Date of authorisation: 19/09/2018, Revision: 19, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Ervebo, Ebola Zaire vaccine (rVSV∆G-ZEBOV-GP, live), Date of authorisation: 11/11/2019, Revision: 14, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Ervebo, Ebola Zaire vaccine (rVSV∆G-ZEBOV-GP, live), Date of authorisation: 11/11/2019, Revision: 14, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Emblaveo, aztreonam,avibactam, Date of authorisation: 22/04/2024, Revision: 4, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Emblaveo, aztreonam,avibactam, Date of authorisation: 22/04/2024, Revision: 4, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Fetcroja, cefiderocol, Date of authorisation: 23/04/2020, Revision: 14, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Fetcroja, cefiderocol, Date of authorisation: 23/04/2020, Revision: 14, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Mektovi, binimetinib, Date of authorisation: 20/09/2018, Revision: 13, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Mektovi, binimetinib, Date of authorisation: 20/09/2018, Revision: 13, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): CellCept, mycophenolate mofetil, Date of authorisation: 14/02/1996, Revision: 44, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): CellCept, mycophenolate mofetil, Date of authorisation: 14/02/1996, Revision: 44, Status: Authorised4 recorded states
Signal first indexedP2 · 99% quality · 2 sources
Source details updatedP2 · 99% quality · 2 sources
Headline updatedP2 · 99% quality · 2 sources
Source details updatedP2 · 99% quality · 2 sources